Literature DB >> 11899233

Receptors for unopsonized particles: the role of alveolar macrophage scavenger receptors.

A Palecanda1, L Kobzik.   

Abstract

The lung is constantly exposed to potentially pathogenic particles and microorganisms. Alveolar macrophage (AM) binding of inhaled environmental particles is a critical first step in phagocytosis and clearance, and must be accomplished without the benefit of opsonization by specific antibodies. Opsonin-independent phagocytosis is initiated by direct recognition of phagocytic target. The identities of receptors on AMs that mediate unopsonized particle binding were, until recently, not known. Using flow cytometry, monoclonal antibody and expression cloning techniques we have found a major role for the scavenger receptor, MARCO in AM binding of particles and bacteria. In this review we will discuss the role of scavenger receptors in AM binding of unopsonized particles and the use of flow cytomety in analyzing AM-particle interaction. We will also discuss other non-scavenger receptors involved in opsonin-independent phagocytosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11899233     DOI: 10.2174/1566524013363384

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  31 in total

1.  Function of macrophage scavenger receptor 1 gene polymorphisms in chronic obstructive pulmonary disease with and without lung cancer in China.

Authors:  Liang Xie; Wei Chen; Ran Dong; Bin He; Kaishun Zhao; Li Zhang; Min Zhou; Ping He
Journal:  Oncol Lett       Date:  2018-03-21       Impact factor: 2.967

2.  Fine ambient particles induce oxidative stress and metal binding genes in human alveolar macrophages.

Authors:  Yuh-Chin T Huang; Zhuowei Li; Jacqueline D Carter; Joleen M Soukup; David A Schwartz; Ivana V Yang
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-27       Impact factor: 6.914

3.  Lung infections and innate host defense.

Authors:  Ma Valdivia-Arenas; A Amer; Ln Henning; Md Wewers; Ls Schlesinger
Journal:  Drug Discov Today Dis Mech       Date:  2007

4.  The phagocytosis of crystalline silica particles by macrophages.

Authors:  Renée M Gilberti; Gaurav N Joshi; David A Knecht
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-12       Impact factor: 6.914

Review 5.  Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities.

Authors:  Sharad Mangal; Wei Gao; Tonglei Li; Qi Tony Zhou
Journal:  Acta Pharmacol Sin       Date:  2017-05-01       Impact factor: 6.150

Review 6.  Lung macrophages: current understanding of their roles in Ozone-induced lung diseases.

Authors:  Sonika Patial; Yogesh Saini
Journal:  Crit Rev Toxicol       Date:  2020-05-27       Impact factor: 5.635

7.  Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-deficient mice.

Authors:  Narsa M Reddy; Vegiraju Suryanarayana; Dhananjaya V Kalvakolanu; Masayuki Yamamoto; Thomas W Kensler; Paul M Hassoun; Steven R Kleeberger; Sekhar P Reddy
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

Review 8.  Macrophages in tuberculosis: friend or foe.

Authors:  Evelyn Guirado; Larry S Schlesinger; Gilla Kaplan
Journal:  Semin Immunopathol       Date:  2013-07-18       Impact factor: 9.623

9.  The biodegradability of electrospun Dextran/PLGA scaffold in a fibroblast/macrophage co-culture.

Authors:  Hui Pan; Hongliang Jiang; Weiliam Chen
Journal:  Biomaterials       Date:  2008-01-14       Impact factor: 12.479

Review 10.  Silica binding and toxicity in alveolar macrophages.

Authors:  Raymond F Hamilton; Sheetal A Thakur; Andrij Holian
Journal:  Free Radic Biol Med       Date:  2007-12-27       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.